SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VISX -- Ignore unavailable to you. Want to Upgrade?

To: Jim Mac who wrote (569)5/14/1998 11:25:00 PM
From: Paul Kelly  Read Replies (1) | Respond to of 1754
 
The point being alleged is that the patents were obtained fraudulently.
If that is the case, they in law and in fact will be invalid and unenforceable. What VISX's competitors have to gain is not relevant.
The patents simply would be found never to have existed.

PK



To: Jim Mac who wrote (569)5/15/1998 8:54:00 AM
From: Andrew Abrams  Respond to of 1754
 
We are currently looking for a patent atty to do the evaluation. I can't figure why the FTC started the patent issue unless they have a reason to believe that they have basis. They could have just filed the PPP suit for restraint of trade. Tried to get them to talk. No chance.

AA


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News